In some studies, increased CD8+/CD4+, CD4+/CD8+, CD3+/Treg, or CD8+/Treg ratios, rather than the absolute counts of individual populations, were correlated with survival outcomes in patients with glioblastoma/glioma (203, 229, 232). This evidence concerns the gene CD8A and glioblastoma.